These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 322257)

  • 21. The requirement for esterase activation in T cell replacing factor (TRF)-induced IgG production in a human B blastoid cell line.
    Miki Y; Kishi H; Muraguchi A; Kishimoto S; Yamamura Y; Kishimoto T
    J Immunol; 1982 Feb; 128(2):675-8. PubMed ID: 6798119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protease activity associated with excystation of Cryptosporidium parvum oocysts.
    Forney JR; Yang S; Healey MC
    J Parasitol; 1996 Dec; 82(6):889-92. PubMed ID: 8973395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical characterization of the human lymphokine leukocyte migration inhibitory factor (LIF): role of cGMP as a specific inhibitor of the LIF esterase activity.
    Bendtzen K
    Adv Exp Med Biol; 1979; 114():485-90. PubMed ID: 223417
    [No Abstract]   [Full Text] [Related]  

  • 25. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase.
    Dentan C; Tselepis AD; Chapman MJ; Ninio E
    Biochim Biophys Acta; 1996 Feb; 1299(3):353-7. PubMed ID: 8597590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of migration inhibitory factor activity by plasma esterase inhibitors.
    Remold HG; Rosenberg RD
    J Biol Chem; 1975 Aug; 250(16):6608-13. PubMed ID: 1099092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylmethylsulfonyl fluoride alters sensitivity to organophosphorus-induced delayed neurotoxicity in developing animals.
    Pope CN; Chapman ML; Tanaka D; Padilla S
    Neurotoxicology; 1992; 13(2):355-64. PubMed ID: 1436755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of guinea pig peritoneal macrophage migration in vitro: effects of protease inhibitors.
    Vilić IM; Prokić LM; Spuzić IV
    Immunol Lett; 1987 Apr; 14(4):271-6. PubMed ID: 2438211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulatory effect of phenylmethylsulfonyl fluoride upon sulfate uptake by costal cartilage.
    McKern NM
    Aust J Biol Sci; 1983; 36(1):35-40. PubMed ID: 6870669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of degradation of human polymorphonuclear leukocyte proteins by diisopropylfluorophosphate.
    Amrein PC; Stossel TP
    Blood; 1980 Sep; 56(3):442-7. PubMed ID: 6773606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temperature-gradient gel electrophoresis for analysis and screening of thermostable proteases.
    Sättler A; Riesner D
    Electrophoresis; 1993 Aug; 14(8):782-8. PubMed ID: 8404822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenylmethylsulfonyl fluoride protects rats from Mipafox-induced delayed neuropathy.
    Veronesi B; Padilla S
    Toxicol Appl Pharmacol; 1985 Nov; 81(2):258-64. PubMed ID: 4060153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditions for the enhancing effect of protease inhibitors on the concanavalin A induced thymidine response of murine lymphocytes.
    Hammann KP; Scheiner O; Raile A; Schulz T; Schopf RE; Peters H; Erdei A; Dierich MP
    Int Arch Allergy Appl Immunol; 1983; 70(4):337-45. PubMed ID: 6826237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of an activatable esterase in immune-dependent phagocytosis by human neutrophils.
    Musson RA; Becker EL
    J Immunol; 1977 Apr; 118(4):1354-65. PubMed ID: 850067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry.
    Zheng N; Fung EN; Buzescu A; Arnold ME; Zeng J
    Rapid Commun Mass Spectrom; 2012 Jun; 26(11):1291-304. PubMed ID: 22555922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inability to block the activity of guinea pig migration inhibitory factor with di-isopropyl phosphorofluoridate.
    David JR; Becker EL
    Eur J Immunol; 1974 Apr; 4(4):287-9. PubMed ID: 4604594
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system.
    Forney JR; Yang S; Du C; Healey MC
    J Parasitol; 1996 Aug; 82(4):638-40. PubMed ID: 8691375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of various serine protease inhibitors on estrogen receptor steroid binding.
    Koffman B; Modarress KJ; Bashirelahi N
    J Steroid Biochem Mol Biol; 1991 May; 38(5):569-74. PubMed ID: 2039753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.